3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Phase 3
1
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Carcinoma, Non-Small-Cell Lung
23
Breast Neoplasms
22
Colorectal Neoplasms
14
Ovarian Neoplasms
12
Lung Neoplasms
10
Neoplasm Metastasis
9
Stomach Neoplasms
8
Neoplasms
8
Nasopharyngeal Carcinoma
8
Leukemia, Myeloid, Acute
7
Triple Negative Breast Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
6
Rectal Neoplasms
6
Fallopian Tube Neoplasms
6
Recurrence
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Esophageal Squamous Cell Carcinoma
5
Uterine Cervical Neoplasms
4
Prostatic Neoplasms
4
Lymphoma, Non-Hodgkin
4
Leukemia
4
Head and Neck Neoplasms
4
Esophageal Neoplasms
4
Carcinoma, Ovarian Epithelial
4
Pancreatic Neoplasms
3
Neoplasms by Site
3
Lymphoma, Large B-Cell, Diffuse
3
Adenocarcinoma
3
Urinary Bladder Neoplasms
2
Multiple Myeloma
2
Interventions
pegaspargase
4
Oxaliplatin
3
Gemcitabine
3
Methotrexate
2
Etoposide
2
Early Intervention, Educational
2
Doxorubicin
2
Dexamethasone
2
sugemalimab
1
ferrous sulfate
1
ferric gluconate
1
Vincristine
1
Thalidomide
1
Sucrose
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Psychiatric Rehabilitation
1
Prednisone
1
Pharmacogenomic Testing
1
Ketamine
1
Drug Therapy
1
Darbepoetin alfa
1
Cyclophosphamide
1
Ciprofloxacin
1
Asian ginseng
1
Amoxicillin-Potassium Clavulanate Combination
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Lymphoma, Extranodal NK-T-Cell
×
Drug Therapy
×
Clear all
NCT00725231
2012-05-07
A-CHOP-14
University of Göttingen
Phase 3
Unknown
274 enrolled